Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03716531 · ClinicalTrials.gov registry record · NA

Electron Beam Intraoperative Radiation Therapy Following Chemoradiation in Patients With Pancreatic Cancer With Vascular Involvement

A NA study of Pancreas Cancer, sponsored by Massachusetts General Hospital.

Active
Registry status
NA
Development phase
199
Enrollment target
6
Study locations

NCT03716531 is a NA study of Pancreas Cancer that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 199 participants, below the 904-participant average among 54 other Pancreas Cancer trials with a reported enrollment target (78% lower). The trial reports 6 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03716531, a NA study of Pancreas Cancer, is active but no longer recruiting, sponsored by Massachusetts General Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
199 participants
Enrollment target
6
Study locations

Study Summary

This research study is studying an intervention as a possible treatment for pancreatic cancer.

Conditions Studied

Interventions

  • RADIATION IORT

Study Locations (6)

California

  • University of California, Irvine - Irvine

Florida

  • Mayo Clinic, Jacksonville - Jacksonville

Massachusetts

  • Massachusetts General Hospital - Boston

Minnesota

  • Mayo Clinic, Rochester - Rochester

North Carolina

  • University of North, Carolina Chapel Hill - Chapel Hill

Ohio

  • Ohio State University Medical Center - Columbus

Trial Details

FieldValue
Enrollment Target 199 participants
Start Date 2019-03-19
Est. Completion 2027-12-31
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT03716531

The ClinicalTrials.gov registry entry for NCT03716531 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 199 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 904-participant average among 54 other Pancreas Cancer trials with a reported enrollment target (78% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pancreas Cancer appearing as the primary indexed condition, and to 1 intervention - of which IORT is the first listed.

NCT03716531 reports 6 study locations spanning 6 distinct geographic areas - top geographies include California, Florida, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03716531 about?

NCT03716531 is a clinical study titled "Electron Beam Intraoperative Radiation Therapy Following Chemoradiation in Patients With Pancreatic Cancer With Vascular Involvement". This research study is studying an intervention as a possible treatment for pancreatic cancer.

What is the current status of trial NCT03716531?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 199 participants. The study started on 2019-03-19. Estimated completion is 2027-12-31.

What conditions does trial NCT03716531 study?

This clinical trial studies the following conditions: Pancreas Cancer.

What interventions are being tested in trial NCT03716531?

The interventions under investigation include: IORT (RADIATION).

Who is sponsoring clinical trial NCT03716531?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03716531 being conducted?

This trial has 6 study locations across California, Florida, Massachusetts, Minnesota, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pancreas Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.